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Abstract Sialylation of glycoproteins and glycolipids plays an
important role during development, regeneration and pathogen-
esis. It has been shown that unnatural sialylation within glial cell
cultures can have distinct effects on their proliferation and
antigenic profiles. These cultures metabolize N-propanoylman-
nosamine (N-propanoylneuraminic acid precursor = P-NAP), a
synthetic non-physiological precursor of neuraminic acid, result-
ing in the expression of N-propanoylneuraminic acid in
glycoconjugates of their cell membranes [Schmidt, C., Stehling,
P., Schnitzer, J., Reutter, W. and Horstkorte, R. (1998) J. Biol.
Chem. 273, 19146^19152]. To determine whether these bio-
chemically engineered sialic acids influence calcium concentra-
tions in cells of the oligodendrocyte lineage, mixed glial cultures
of oligodendrocytes growing on top of an astrocyte monolayer
were exposed to glutamate, histamine, adrenaline, Q-aminobu-
tyric acid (GABA), high potassium (high K) and ATP. Calcium
responses in P-NAP-treated oligodendrocytes were determined
by confocal microscopy with the calcium indicator fluo-3 AM,
and compared with control cultures. We showed that P-NAP
differentially modulated the calcium responses of individual
oligodendrocytes when GABA was applied. GABA induced
calcium oscillations with up to four spikes per min in 60% of
oligodendrocytes when treated with P-NAP. ß 2000 Federa-
tion of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
N-Acylneuraminic acids or sialic acids are involved in a
variety of biological functions, such as proliferation, cell^cell
interaction and migration (for review, see [1]). It is conceiv-
able that all these parameters might be a¡ected if sialylation is
altered. Alteration of sialylation is in principle possible with
neuraminidases which remove sialic acid from the cell mem-
brane or with inhibitors of sialylation. However, this strategy
seems to be unsuitable for in vitro studies and even less suit-
able for relevant in vivo studies, on account of (i) toxicity, (ii)
tissue permeability and (iii) stability of the neuraminidases or
the inhibitors of sialylation. Another possible strategy for cir-
cumventing these problems is the biochemical engineering of
sialic acid. This is achieved by the application of synthetic N-
acylmannosamines which are metabolized to the respective
engineered neuraminic acid and incorporated into serum
and membrane glycoconjugates. These synthetically derivat-
ized neuraminic acid precursors are generally well tolerated
by all cell types tested so far, when simply added to the cul-
ture medium or even applied orally to the animal [2^7]. The
expression of modi¢ed N-propanoylneuraminic acid by
MDCK host cells prevents the infection by in£uenza A virus.
It has been suggested that this depends on a steric hindrance
of the modi¢ed sialylated receptor [8]. Furthermore, the con-
version from N-acetyl- to N-glycolylmannosamine pentaace-
tate as biosynthetic precursor prevents the binding of myelin-
associated glycoprotein to neural cells [2]. The new method
for the biochemical engineering of sialic acids has been ex-
tended by the group of Carolyn Bertozzi. They used N-acyl-
mannosamine in which the acyl group contained a ketone
structure, namely N-levulinoylmannosamine. This was also
converted to the respective N-levulinoylneuraminic acid and
the unique functional group was exposed on the cell surface
where the ketone may serve as a tag for chemoselective con-
jugation with any molecule containing a hydrazide or amino-
oxy group [4,9].
We have started to analyze the putative consequences of
remodeling neuraminic acids in the central nervous system
and demonstrated earlier that the behavior of glial cells is
in£uenced. The proliferation of microglia and astrocytes is
increased by N-propanoylneuraminic acid precursor (P-
NAP) [3]. Oligodendrocytes show increased signs of a non-
mature cell stage upon the application of P-NAP shown by
the expression of the A2B5 epitope [3]. Oligodendrocytes
which develop constitutively into myelin-forming cells in vitro
and in vivo (for review, see [10]) are functionally impaired in a
number of severe neurological diseases such as multiple scle-
rosis.
The present study was designed to investigate whether sig-
nal transduction in the nervous system is a¡ected by modi¢-
cation of the side chain of sialic acids and we concentrated on
the investigation of the second messenger calcium. Substances
such as glutamate, histamine, adrenaline and Q-aminobutyric
acid (GABA), as well as high potassium concentrations (high
K), each of which is known to increase intracellular calcium
concentrations in glial cells, were applied to P-NAP-treated
oligodendrocytes in a mixed glial cell culture, and compared
with control cultures.
We found a strong GABA-dependent oscillation of intra-
cellular calcium concentrations in oligodendrocytes treated
with P-NAP.
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We propose that biosynthetic modi¢cation of the side chain
of sialic acid in conjunction with the activation of GABA
receptors is a potent tool for modulating calcium concentra-
tions in oligodendrocytes.
2. Materials and methods
2.1. Preparation of mixed glial cell cultures
Mixed glial cell cultures from whole brains of neonatal Wistar rats
were prepared according to the method of McCarthy and de Vellis
[11] and plated onto glass coverslips (11 mm diameter) coated with
poly-L-lysine (P1524, Sigma, Deisenhofen, Germany; 20 Wg/ml in
water). Cells were maintained in basal Eagle’s medium (Gibco, Karls-
ruhe, Germany) supplemented with 10% horse serum (Gibco). It is
well established that neurons do not survive under these culture con-
ditions. After 7 þ 2 days in culture, cells were grown to con£uency
until oligodendrocytes were lying on top of an astrocyte monolayer.
Thereafter, cultures were maintained for 2 days in the presence or
absence of N-acylneuraminic acid precursors (see below) at a concen-
tration of 5 mM and 37‡C, 5% CO2, 95% humidity.
2.2. Solutions and reagents
The physiological precursor of neuraminic acid is N-acetylmannos-
amine (N-acetylneuraminic acid precursor or A-NAP). N-Acetylman-
nosamine was purchased from Sigma (Deisenhofen, Germany). N-
Propanoylmannosamine (P-NAP) was synthesized as described by
Kayser et al. [6]. Matrix-assisted laser desorption ionization analysis
of P-NAP preparations revealed no contaminating material. All other
reagents were obtained from Sigma. Solutions used for calcium imag-
ing were freshly prepared from refrigerated stocks. The standard bath-
ing solution for calcium imaging was permanently gassed with carb-
ogen and contained 134 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 1.3
mM MgCl2, 1.25 mM K2HPO4, 26 mM NaHCO3, 10 mM glucose,
pH adjusted to 7.4 with NaOH at room temperature. For a calcium-
free solution, CaCl2 was omitted and 0.5 mM EGTA was added.
Fluo-3 acetoxymethylester (£uo-3 AM) was obtained from Molecular
Probes (Eugene, OR, USA).
2.3. Calcium [Ca2+measurements
Changes in intracellular calcium were quanti¢ed according to the
method described by Bernstein et al. [12]. In brief, glial cultures were
rinsed in P-NAP-free medium and loaded with 2.5 WM £uo-3 AM for
30 min in bathing solution at 37‡C, 5% CO2 in the incubator. There-
after, cultures were superfused continuously with bathing solution.
For measuring changes of the intracellular calcium concentrations, a
confocal laser scanning microscope (Sarastro 2000: Molecular Dy-
namics, Sunnyvale, CA, USA) was used to distinguish oligodendro-
cytes lying on astrocyte monolayers. A 200 Wm pinhole was selected to
adjust the thickness of the image plane from which the £uorescence
was collected by the confocal system to less than 5 Wm. The scanner
was mounted on an upright microscope (Axioscope, Zeiss, Oberko-
chen, Germany) equipped with 20Umagni¢cation. The non-ratiomet-
ric Ca2 indicator, £uo-3, was used to provide information about
changes in relative calcium concentrations. Fluo-3 was excited at
488 nm with an argon laser, and the £uorescence was measured at
an emission wavelength above 510 nm and selected with a long-pass
¢lter. Images were acquired every 4 s. Acquisition of the £uorescence
data and image analysis were performed using Imagespace (Molecular
Dynamics) and standard PC evaluation software.
2.4. Immunohistochemistry
Mixed glial cell cultures were stained with mouse monoclonal anti-
bodies directed against the O4 (Roche Molecular Biochemicals,
Mannheim, Germany), a marker for cells of the oligodendrocyte lin-
eage [13]. Non-¢xed cells were stained directly after calcium imaging
had been performed on the stage of the upright microscope. Thus, it
was possible to correlate calcium responses with individual cells. The
primary antibody was incubated for 5 min in bathing solution. After
extensive superfusion with bathing solution, chain-speci¢c Cy3-conju-
gated secondary antibody (Dianova, Hamburg, Germany) was ap-
plied for another 5 min.
Fig. 1. Morphological characterization of oligodendrocytes of mixed glial cultures that have been maintained for 2 days in the absence (control)
and in the presence of P-NAP. Left panel: phase contrast micrographs of astrocyte monolayers with oligodendrocytes growing on top of them.
Right panel: O4 immunohistochemical staining of oligodendrocytes. Examples of O4-positive oligodendrocytes are marked with arrows.
Bar = 12 Wm.
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3. Results
3.1. Morphological characterization of oligodendrocytes in the
presence and in the absence of chemically engineered sialic
acids
Astrocytes provide a preferable substratum for oligoden-
drocytes in vitro [14,15] and are also in close contact with
each other in vivo [16^18]. Thus, mixed glial cultures were
grown to con£uency until process-bearing oligodendrocytes
were growing on top of a con£uent astrocytic monolayer
(Fig. 1). These cultures were then maintained for 2 days in
the presence and in the absence of 5 mM of N-propanoylman-
nosamine (P-NAP). It has been reported that mixed glial cell
cultures incorporate and metabolize P-NAP and express it on
glycoproteins of the cell membrane [3]. We used the O4 anti-
body for immunohistochemical identi¢cation of oligodendro-
cytes. The majority of all cells lying on top of the astrocytes
were O4-positive with only a few processes (Fig. 1, arrows).
There was no di¡erence in the number or morphology of O4-
positive cells in the presence and in the absence of P-NAP
(Fig. 1), or in the presence of N-acetylmannosamine, the phys-
iological precursor of neuraminic acid (N-acetylneurmaninic
acid precursor, or A-NAP; data not shown).
3.2. P-NAP alters GABA-dependent calcium transients of
oligodendrocytes
In order to functionally characterize the O4-positive oligo-
dendrocytes, a series of mediators of signal transduction path-
ways were applied. Here, we concentrated on the e¡ects on
calcium responses.
We determined the calcium transients in oligodendrocytes
evoked by glutamate, histamine, adrenaline, GABA and high
K in an application sequence in P-NAP- or A-NAP-treated
and non-treated cultures. To depolarize the oligodendrocytes
to the threshold for the activation of voltage-gated Ca2 chan-
nels, high K was applied at a concentration of 50 mM. All
other substances were applied at 1 mM. Oligodendrocytes
cultured in the presence or absence of P-NAP responded to
all of the applied substances with an increase of intracellular
calcium concentration (Fig. 2). During one experiment, an
apparent decreased responsiveness to the applied substances
was observed at the end of each application sequence, indicat-
ing a decrease of the number of reactive cells (Fig. 2). How-
ever, each substance led to an increase of the intracellular
calcium concentration in up to 90% of the oligodendrocytes
when applied ¢rst (data not shown). The number of cells
reacting with an increase in intracellular calcium concentra-
tion was not signi¢cantly di¡erent between cultures main-
tained in the absence or in the presence of P-NAP (Fig. 2).
In control experiments under calcium-free conditions, only
very few oligodendrocytes reacted to GABA (data not
shown).
Fig. 2. Quanti¢cation of oligodendrocytes of mixed glial cultures re-
acting with an increase in intracellular calcium concentration upon
the application of a series of substances. Cells were maintained for
2 days in the absence (control) and in the presence of P-NAP. Glu-
tamate, adrenaline, histamine, GABA and high K were applied se-
quentially at a concentration of 1 mM, except high K which was
applied at a concentration of 50 mM. Substances were applied for
30 s, except GABA which was applied for 1 min. Bars represent
mean values þ S.D. from three independent experiments with 25 cells
in each group.
Fig. 3. The calcium signals of a group of oligodendrocytes (22^25 cells) subjected to a series of substances are shown in one representative set
of experiments. Cultures of oligodendrocytes growing on top of astrocyte monolayers were maintained for 2 days in the absence (control) or
presence of A-NAP or P-NAP. Substances were applied for 30 s, except GABA which was applied for 1 min. Between each application, cul-
tures were allowed to recover for 10 min (//). Glutamate, adrenaline, histamine and GABA were applied at a concentration of 1 mM, and K
at 50 mM. To test the viability of the cultures, 100 WM ATP was applied. Note the prominent additional and elevated calcium spike upon the
application of GABA in P-NAP-treated cultures, compared with the control and A-NAP-treated cultures (boxes).
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However, when GABA was applied, P-NAP-treated cul-
tures reacted di¡erently compared with control cultures with
respect to relative intracellular calcium concentrations. When
GABA was applied for 1 min in the presence of external
calcium, a second calcium spike appeared in P-NAP-treated
oligodendrocytes. (Fig. 3, compare boxes and Fig. 4C, anoth-
er independent experiment showing calcium traces of groups
of oligodendrocytes). The additional prominent spike was not
present in the control experiments in the absence (Figs. 3 and
4B) or presence of A-NAP (Fig. 3). 43 þ 23% single oligoden-
drocytes in P-NAP-treated cultures showed this characteristic
second spike compared with 4 þ 3% of the non-treated con-
trols (Fig. 4A) or A-NAP-treated controls (data not shown).
In P-NAP-treated cells, the second calcium spike induced by
GABA was often even more pronounced than the ¢rst rise in
intracellular calcium (Figs. 3 and 4C, and see also the calcium
trace of a single oligodendrocyte in Fig. 5A).
3.3. Increased calcium spiking e⁄cacy with prolonged
application of GABA in oligodendrocytes pretreated with
P-NAP
Our ¢ndings suggest that GABA leads to an oscillation of
intracellular calcium concentrations in P-NAP-treated cul-
tures. When GABA was applied for longer periods in the
presence of external calcium to cultures that had been incu-
bated with P-NAP, an increase in homogeneous calcium spik-
ing and heterogeneous calcium spiking, i.e. multipeak calcium
spiking, was observed. Fig. 5A shows a representative exam-
ple of an oligodendrocyte which was subjected to 1 and 3 min
GABA, showing 1^4 spikes/min. The calcium oscillation
could also be extended to 4 min with the application of
GABA (data not shown). However, frequencies and ampli-
tudes of the calcium responses were heterogeneous from ex-
periment to experiment. 60 þ 21% of all oligodendrocytes in P-
NAP-treated cultures show 2^4 spikes per min when GABA
was applied. Only 23 þ 7% of the non-treated control cells
showed these kinds of calcium traces upon the application
of GABA (Fig. 5B). No comparable calcium oscillations
were observed in those few cells which reacted towards
GABA under calcium-free conditions (data not shown).
Calcium responses were in general immediate. Only a few
cells reacted with a delay of 24 þ 5 s. In all cultures, sponta-
neous calcium spiking, i.e. the generation of spikes not di-
rectly related to the application of any substance, was the
same (data not shown).
4. Discussion
In this study, we demonstrate that the signal transducer
calcium is di¡erently modulated in P-NAP-treated oligoden-
drocyte cultures compared with cultures grown in the absence
of P-NAP or in the presence of the natural precursor of neu-
raminic acid A-NAP. We observed a prominent oscillation of
intracellular calcium concentration in P-NAP-treated oligo-
dendrocytes when GABA was applied.
Glial cells play an active part during information process-
Fig. 4. (A) Quanti¢cation of oligodendrocytes reacting with a second increase of intracellular calcium concentration upon the application of
GABA for 1 min. Cultures were maintained in the absence (control) and in the presence of P-NAP for 2 days. Bars represent mean values þ
S.E.M. from three independent experiments. (B,C) Representative set of experiments showing the sums of calcium traces of groups of oligoden-
drocytes (22^25 cells) in the absence (B) and in the presence of P-NAP (C). Note the elevated second calcium spike in P-NAP-treated oligoden-
drocytes. The £uo-3 signals were recorded every 4 s (frames).
Fig. 5. (A) GABA was applied in the presence of extracellular calcium (GABA+Ca2) for 1 and 3 min to an oligodendrocyte of a mixed glial
culture that had been incubated with P-NAP for 2 days. Note the increase of homogeneous calcium spiking with prolonged incubation time.
(B) Quanti¢cation of oligodendrocytes that showed spiking during the application of GABA (vtwo spikes). Bars represent mean values þ
S.E.M. from three independent experiments.
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ing, growth, di¡erentiation and regeneration in the nervous
system. Oligodendrocytes express cell adhesion molecules such
as the neural cell adhesion molecule, neurotransmitter recep-
tors such as GABA receptors and also speci¢c glycolipids
such as A2B5 on their cell surfaces. One common component
of all these molecules is N-acetylneuraminic acid, the terminal
monosaccharide of most glycoconjugates. Biochemical engi-
neering of neuraminic acids via the unnatural precursor P-
NAP and the incorporation of N-propanoylneuraminic acid
instead of the natural N-acetylneuraminic acid in all glyco-
conjugates has been shown to modulate several oligodendro-
cyte functions [3].
The observation of calcium oscillations in intact tissues and
the recognition of calcium-dependent processes that are
adapted to frequency-modulated oscillatory calcium signals
point to a physiological signi¢cance of this phenomenon
[19]. Calcium oscillations in astrocytes are thought to repre-
sent a highly plastic signaling system that underlies the recip-
rocal communication between neurons and astrocytes [20]. It
has been shown that glutamate induces calcium spikes in as-
trocytes [21,22] with a frequency of 4^7 spikes per min. Our
results show that the frequency of GABA-induced spikes in
oligodendrocytes was in the range of up to four spikes/min.
It has been reported that platelet-derived growth factor
(PDGF)-BB induces both oscillatory and non-oscillatory
Ca2 responses in cultured oligodendrocytes, grown either
as O-2A progenitors or di¡erentiated oligodendrocytes [23].
It was concluded that intracellular levels of sphingosine and
sphingosine 1-phosphate di¡erentially modulate calcium sig-
naling triggered by PDGF receptor stimulation in these cells
[24]. The functional consequences of oscillatory and non-os-
cillatory calcium responses are not yet clear. They may re£ect
the complex action of signal transducers, such as growth fac-
tors and neurotransmitters in oligodendrocytes. Di¡erential
signal processing may provide a mechanism whereby calcium
controls diverse cellular functions via di¡erent signaling path-
ways, as shown for neuronal cells where the mode of calcium
entry determines distinct gene expression [25].
Since our understanding of glial^glial interactions is only
sparse, it remains unclear whether the observed calcium re-
sponses in oligodendrocytes growing on astrocytes are direct
or indirect. Astrocytes are in general also responsive to the
applied substances [12,26,27]. Thus, it is possible that the
stimulation of the underlying astrocytes leads to an indirect
e¡ect: the application of the substances (i.e. via intracellular
calcium increase) might release a second e¡ector which, in
turn, stimulates the oligodendrocyte lying on top of the as-
trocytes. However, the immediacy of the oscillatory calcium
transients suggests a direct response of the oligodendrocytes.
In a number of cases, we observed a second increase in
intracellular calcium in P-NAP-treated cells which was even
more prominent than the immediate ¢rst answer after the
external stimulus GABA. It remains to be further analyzed
whether this might be due to a P-NAP-dependent activation
of voltage-operated calcium channels.
Ionotropic GABA receptors are sialylated glycoproteins, as
shown by lectin binding studies and neuraminidase treatment
[28,29]. We propose a modulation of neurotransmitter-in-
duced calcium transients in oligodendrocytes after unnatural
sialylation of ionotropic GABA receptors and possibly other
glycoconjugates using the biochemically engineered P-NAP. It
remains to be elucidated whether an altered sialylation of
GABA receptors might directly account for the intracellular
calcium signals observed during the application of GABA. P-
NAP-dependent alteration in the sialylation of glycoproteins
may provide a means for intracellular or intercellular infor-
mation coding.
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